IAVARONE, MASSIMO ALBERTO
IAVARONE, MASSIMO ALBERTO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
The Predictive Role of [18F]FDG PET/CT in Early HCC Recurrence After Liver Transplantation
2026 E. Alimenti, L. Canova, M. Iavarone, G. Aldinio, D. Dondossola, L. Florimonte, E. Franchi, G. Marini, C. Dibenedetto, L. Caccamo, F. Cerini, M. Castellani, C. Quintini, P. Lampertico
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study
2025 A. Vitale, J.S. Kim, G. Cabibbo, A. Casadei-Gardini, M. Iavarone, L. Rimassa, F.R. Ponziani, F. Tovoli, H.J. Chon, B. Kang, C. Kim, H. Imaoka, M. Ikeda, M. Kudo, T. Aoki, R. Tortora, M. Guarracino, B. Stefanini, M. Marseglia, A. Sparacino, C. Celsa, M. Bruccoleri, E. Alimenti, F. Marra, C. Campani, S. Bhoori, V. Mazzaferro, R. Sacco, A. Facciorusso, A. Martini, L. Stella, L. Cerrito, H. Toyoda, S. Yasuda, F. Rossari, M. Rimini, G. Suda, T. Sho, G. Masi, C. Vivaldi, T. Pressiani, S. Kakizaki, A. Naganuma, A. Avallone, A. Nappi, G. Vidili, C. Soldà, F. Bergamo, D.J. Pinato, F. Pelizzaro, F.G. Foschi, A. Secomandi, F. Verderame, E. Bronte, E. Martinelli, D. Marino, S. Grasselli, A. Olivani, M.R. Brunetto, F. Damone, A. Mega, L. Marzi, E. Tamburini, M. Ramundo, P. Federico, B. Daniele, E.G. Giannini, A. Pasta, F. Morisco, M. Guarino, C. Hoyek, S. Boninsegna, A. Gupta, D. Sacerdoti, A. Dalbeni, I. Calvo Ramos, J. Adeva, C. Saitta, C. Pitrone, M.L. Lentini Graziano, N. Farella, M. Rendina, T. Grassi, M.G. Rodriquenz, E. Maiello, J. Presa, I. Pinho, Y. Hiasa, M. Hirooka, J. Chen, G. Arrichiello, C. Aschele, A. Furlanetto, U. Cillo
Neoadjuvant atezolizumab plus bevacizumab prior liver transplantation for hepatocellular carcinoma
2025 P. Tabrizian, R. Marino, S. Bhoori, M. Zeitlhoefler, N. Mehta, V. Banz, S. Gruttadauria, M. Iavarone, C. Mazzarelli, N. Simonotti, F. Yao, V. Mazzaferro, J.M. Llovet
Management of patients with advanced HCC receiving atezolizumab/bevacizumab: Take care of cirrhosis!
2025 J. Nault, M. Iavarone
We need evidence-based futility thresholds to transplant grade-3 acute on chronic liver failure patients with poor respiratory, haemodynamic, and metabolic parameters
2025 A.W. Avolio, M. Antonelli, L. Caccamo, F. Frongillo, L. Del Prete, A. Ferrarese, M. Iavarone, P. Burra
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study
2025 M. Iavarone, E. Alimenti, M. Puoti, H. Hasson, B. Monti, S. Bhoori, F. Peracchi, A. Siribelli, M. Fava, M. Bruccoleri, M. Merli, G. Morsica, A. De Silvestri, P. Bonfanti, A. Castagna, A. Soria, P. Lampertico
The impact of BCLC recommendations on survival for patients with hepatocellular carcinoma
2025 M. Iavarone, E. Alimenti, L. Canova, M. Bruccoleri, B. Antonelli, A.M. Ierardi, A. Sangiovanni, G. Cabibbo, A. De Silvestri, L. Caccamo, G. Carrafiello, P. Lampertico
Pioneering applications of immunotherapy in the early stages of hepatocellular carcinoma
2024 E. Alimenti, L. Erica Nicola, N. Leonardo Antonio, M.A. Iavarone
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis
2024 S. Di Cola, G. D'Amico, P. Caraceni, F. Schepis, S. Loredana, P. Lampertico, P. Toniutto, S. Martini, S. Maimone, A. Colecchia, G. Svegliati Barone, C. Alessandria, A. Aghemo, S.L. Crocè, L.E. Adinolfi, M. Rendina, L. Lapenna, E. Pompili, G. Zaccherini, D. Saltini, M. Iavarone, G. Tosetti, C. Martelletti, V. Nassisi, A. Ferrarese, I. Giovo, C. Masetti, N. Pugliese, M. Campigotto, R. Nevola, M. Merli
Palliative care in patients with hepatocellular carcinoma: Results from a survey among hepatologists and palliative care physicians
2024 M. Iavarone, L. Canova, E. Alimenti, A. Aghemo, D. Taveggia, G. Gobber, G. Cabibbo, S. Veronese, V. Calvaruso, L. Orsi, P. Caraceni, P. Lampertico
Impact of Pre-Liver Transplant Treatments on the Imaging Accuracy of HCC Staging and Their Influence on Outcomes
2024 E. Franchi, D.E. Dondossola, G.M.F. Marini, M. Iavarone, L. Del Prete, C. Di Benedetto, M.F. Donato, B. Antonelli, P. Lampertico, L. Caccamo
Incidence and Predictors of Esophagogastric Varices Bleeding in Patients with Hepatocellular Carcinoma in Lenvatinib
2024 M. Iavarone, E. Alimenti, T. Tada, S. Shimose, G. Suda, C. Yoo, C. Soldà, F. Piscaglia, G. Tosetti, F. Marra, C. Vivaldi, F. Conti, M. Schirripa, H. Iwamoto, T. Sho, S.H. Lee, M.D. Rizzato, M. Tonnini, M. Rimini, C. Campani, G. Masi, F. Foschi, M. Bruccoleri, T. Kawaguchi, T. Kumada, A. Hiraoka, M. Atsukawa, S. Fukunishi, T. Ishikawa, K. Tajiri, H. Ochi, S. Yasuda, H. Toyoda, T. Hatanaka, S. Kakizaki, K. Kawata, F. Tada, H. Ohama, N. Itokawa, T. Okubo, T. Arai, M. Imai, A. Naganuma, A. Casadei-Gardini, P. Lampertico
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipients
2024 S.M. Murray, E. Pose, M. Wittner, M. Londoño, G. Schaub, J. Cook, S. Dimitriadis, G. Meacham, S. Irwin, Z. Lim, P. Duengelhoef, M. Sterneck, A.W. Lohse, V. Perez, P. Trivedi, K. Bhandal, B.H. Mullish, P. Manousou, N.M. Provine, E. Avitabile, M. Carroll, T. Tipton, S. Healy, P. Burra, P. Klenerman, S. Dunachie, B. Kronsteiner, A.K. Maciola, G. Pasqual, V. Hernandez-Gea, J.C. Garcia-Pagan, P. Lampertico, M. Iavarone, P. Gines, M. Lütgehetmann, J. Schulze Zur Wiesch, F.P. Russo, E. Barnes, T. Marjot
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study
2023 M. Iavarone, G. Tosetti, F. Facchetti, M. Topa, J. Ming Er, S. Kit Hang, D. Licari, A. Lombardi, R. D'Ambrosio, E. Degasperi, A. Loglio, C. Oggioni, R. Perbellini, R. Caccia, A. Bandera, A. Gori, F. Ceriotti, L. Scudeller, A. Bertoletti, P. Lampertico
Induced myocardial ischemia in candidates to liver transplantation without evidence of heart disease
2023 L. Mircoli, N. Bacà, B. Antonelli, L. Caccamo, E. Cattaneo, F. Colombo, C. Dibenedetto, L. Diehl, M.F. Donato, A. Faggiano, M.A. Iavarone, P. Lampertico, C. Marenghi, F. Polli, E. Quarenghi, F.B. Sozzi, C. Spaziani, G. Tosetti, C. Valsecchi, P. Vicardi, M. Vicenzi, A. Zefelippo, M. Ruscica, S. Carugo
Clinical Impact of a Protocol Involving Cone-Beam CT (CBCT), Fusion Imaging and Ablation Volume Prediction in Percutaneous Image-Guided Microwave Ablation in Patients with Hepatocellular Carcinoma Unsuitable for Standard Ultrasound (US) Guidance
2023 P. Biondetti, A.M. Ierardi, E. Casiraghi, A. Caruso, P. Grillo, S. Carriero, C. Lanza, S.A. Angileri, A. Sangiovanni, M. Iavarone, G. Guzzardi, G. Carrafiello
Prothrombin induced by vitamin K absence or antagonist-II and alpha foetoprotein to predict development ofhepatocellular carcinoma in Caucasian patients with hepatitis C-related cirrhosis treated with direct-acting antiviral agents.
2022 E. Degasperi, R. Perbellini, R. D'Ambrosio, S.C. UCEDA RENTERIA, F. Ceriotti, A. Perego, C. Orsini, M. Borghi, M. Iavarone, M. Bruccoleri, A. Rimondi, A. De Silvestri, A. Sangiovanni, P. Lampertico
Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib
2022 V. Sapena, M. Iavarone, L. Boix, F. Facchetti, M. Guarino, M. Sanduzzi Zamparelli, A. Granito, E. Samper, M. Scartozzi, J. Corominas, G. Marisi, A. Díaz, A. Casadei-Gardini, L. Gramantieri, P. Lampertico, F. Morisco, F. Torres, J. Bruix, M. Reig
Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR
2022 R. D'Ambrosio, E. Degasperi, M. Anolli, I. Fanetti, M. Borghi, R. Soffredini, M. Iavarone, G. Tosetti, R. Perbellini, A. Sangiovanni, V. Sypsa, P. Lampertico
An unprecedented challenge: The north italian gastroenterologist response to COVID-19
2022 G.E. Tontini, G. Aldinio, N. Nandi, A. Rimondi, D. Consonni, M. Iavarone, P. Cantu, A. Sangiovanni, P. Lampertico, M. Vecchi